Machine learning powered assays reveal cytotoxicity and immuno-oncology insights

Learn how Nanolive’s high-content live cell imaging solution for label-free, machine learning powered assays can enhance drug discovery with insights into cytotoxicity and immuno-oncology. Hope Amos, Scientific Communication Specialist, Nanolive SA, discusses the company’s unique holotomography technology and explains how this technology enables high-resolution, 3D imaging of the nucleus, mitochondria, and cell membranes. Hear how these assays are being developed to identify metabolic stress in the absence of cell death.

Interview filmed at ELRIG Drug Discovery 2023.